Wuxi Biortus Biosciences Funding: $46M Raised, Series B
Wuxi Biortus Biosciences is based in Jiangyin, China. It has raised $46M in total funding. Latest round: Series B.
Wuxi Biortus Biosciences funding overview
Wuxi Biortus Biosciences is based in Jiangyin, China. Wuxi Biortus Biosciences has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2021. The round record for Wuxi Biortus Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Kangjun Capital, Legend Capital, Sherpa Healthcare Partners, Bayland Capital. 4 distinct backers are named across the disclosed rounds.
Wuxi Biortus Biosciences at a glance
Total raised
$46M
Latest round
Series B
Latest round date
November 2021
Headquarters
Jiangyin, China
Notable investors
Kangjun Capital, Legend Capital, Sherpa Healthcare Partners, Bayland Capital
Frequently asked about Wuxi Biortus Biosciences funding
How much has Wuxi Biortus Biosciences raised?
Wuxi Biortus Biosciences has raised $46M in total disclosed funding across the rounds on record.
Who has invested in Wuxi Biortus Biosciences?
Kangjun Capital, Legend Capital, Sherpa Healthcare Partners, Bayland Capital are named among the investors backing Wuxi Biortus Biosciences.
What was the latest Wuxi Biortus Biosciences funding round?
The most recent disclosed round is a Series B, announced in November 2021.
Where is Wuxi Biortus Biosciences based?
Wuxi Biortus Biosciences is based in Jiangyin, China.
When did Wuxi Biortus Biosciences last raise?
The last disclosed Wuxi Biortus Biosciences round closed in November 2021 at Series B.
Totals shown for Wuxi Biortus Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Jiangyin and the investors behind them below.
Companies related to Wuxi Biortus Biosciences (32)
